Related Experiment Videos
Continuing Ketogenic Diet Therapy in Setting of Hypercalcemia
Leslie Sarabia1, Abby Wetzel1, Jackson Sawyer1
1Indiana University School of Medicine and Riley Hospital for Children, Indianapolis, IN, USA.
None:
ObjectiveHypercalcemia is an uncommon, serious adverse effect of ketogenic diet therapy (KDT). This case highlights the management of hypercalcemia without discontinuing KDT.MethodsOur case study involves a retrospective chart analysis of one patient who developed hypercalcemia during KDT for seizure management.ResultsA 16-year-old male patient with cerebral palsy and intractable epilepsy acutely developed hypercalcemia after receiving KDT for 5 years. Despite hydration and discontinuation of calcium supplementation, hypercalcemia persisted. He was treated with pamidronate 0.3 mg/kg (dose renally adjusted) followed by 0.03 mg/kg intravenous zoledronate with reduction in serum calcium levels. KDT was continued.ConclusionsStandardized guidelines for managing hypercalcemia in adolescent patients with chronic KDT do not exist. More research is needed to guide management and monitoring while preserving seizure control with KDT.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Skeleton and Calcium Homeostasis
Diabetic Ketoacidosis ll: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...